Say on Pay votes and director elections that failed or nearly failed, and stockholder proposals that passed or came closest to passing. Each list is sorted by distance from the pass/fail line rather than a fixed cutoff — the notable cases sit at the top.
Vote results sourced from 8-K Item 5.07 filings. Results are informational only and do not constitute investment advice or a proxy solicitation.
Sorted by lowest support first — failed votes lead, near-misses follow.
| Company | % For | Outcome | Our determination |
|---|---|---|---|
| TGTX — TG THERAPEUTICS INC | 54.3% | passed | AGAINST |
| AXON — AXON ENTERPRISE INC | 66.7% | passed | AGAINST |
| KROS — KEROS THERAPEUTICS INC | 78.4% | passed | FOR |
| ATEX — ANTERIX INC | 82.1% | passed | FOR |
| PTEN — PATTERSON UTI ENERGY INC | 82.3% | passed | FOR |
| DXCM — DEXCOM INC | 89.3% | passed | FOR |
| RPRX — ROYALTY PHARMA PLC CLASS A | 90.9% | passed | FOR |
| ALGM — ALLEGRO MICROSYSTEMS INC | 91.0% | passed | FOR |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | 91.2% | passed | AGAINST |
| JPM — JPMORGAN CHASE & CO | 91.5% | passed | FOR |
| RPRX — ROYALTY PHARMA PLC CLASS A | 91.5% | passed | FOR |
| GH — GUARDANT HEALTH INC | 92.5% | passed | FOR |
| UNF — UNIFIRST CORP | 93.4% | passed | FOR |
| RPRX — ROYALTY PHARMA PLC CLASS A | 95.4% | passed | FOR |
| NTRA — NATERA INC | 95.8% | passed | FOR |
| EXEL — EXELIXIS INC | 96.9% | passed | FOR |
| SLGN — SILGAN HOLDINGS INC | 97.2% | passed | AGAINST |
| NVCR — NOVOCURE LTD | 97.2% | passed | FOR |
| FOLD — AMICUS THERAPEUTICS INC | 97.4% | passed | FOR |
| ACAD — ACADIA PHARMACEUTICALS INC | 98.0% | passed | FOR |
| RVMD — REVOLUTION MEDICINES INC | 98.2% | passed | FOR |
| BEAM — BEAM THERAPEUTICS INC | 99.2% | passed | FOR |
Showing 22 of 22 rows.
Sorted by lowest support first — failed nominees lead, closest calls follow.
| Company | Nominee | % For | Result |
|---|---|---|---|
| UNF — UNIFIRST CORP | Arnaud Ajdler | 19.4% | Failed election |
| UNF — UNIFIRST CORP | Michael A. Croatti | 20.1% | Failed election |
| Closest calls below | |||
| TGTX — TG THERAPEUTICS INC | Sagar Lonial, MD | 54.1% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Athena Countouriotis, M.D. | 56.6% | Elected |
| KROS — KEROS THERAPEUTICS INC | Mary Ann Gray, Ph.D. | 57.8% | Elected |
| TGTX — TG THERAPEUTICS INC | Yann Echelard | 58.6% | Elected |
| TGTX — TG THERAPEUTICS INC | Daniel Hume | 58.9% | Elected |
| TGTX — TG THERAPEUTICS INC | Kenneth Hoberman | 60.5% | Elected |
| FOLD — AMICUS THERAPEUTICS INC | Michael G. Raab | 60.9% | Elected |
| KROS — KEROS THERAPEUTICS INC | Alpna Seth, Ph.D. | 63.6% | Elected |
| NTRA — NATERA INC | Gail Marcus | 70.8% | Elected |
| GH — GUARDANT HEALTH INC | Musa Tariq | 71.3% | Elected |
| AXON — AXON ENTERPRISE INC | Hadi Partovi | 76.8% | Elected |
| UNF — UNIFIRST CORP | Joseph M. Nowicki | 78.0% | Elected |
| UNF — UNIFIRST CORP | Steven S. Sintros | 79.5% | Elected |
| TGTX — TG THERAPEUTICS INC | Laurence N. Charney | 80.6% | Elected |
| NTRA — NATERA INC | Roy Baynes | 80.9% | Elected |
| RVMD — REVOLUTION MEDICINES INC | Thilo Schroeder, Ph.D. | 80.9% | Elected |
| KROS — KEROS THERAPEUTICS INC | Ran Nussbaum | 81.1% | Elected |
| SLGN — SILGAN HOLDINGS INC | Brad A. Lich | 81.6% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Iain Dukes, D. Phil. | 82.2% | Elected |
| RVMD — REVOLUTION MEDICINES INC | Sandra J. Horning, M.D. | 85.5% | Elected |
| RVMD — REVOLUTION MEDICINES INC | Sushil Patel, Ph.D. | 85.5% | Elected |
| TGTX — TG THERAPEUTICS INC | Michael S. Weiss | 85.5% | Elected |
| BEAM — BEAM THERAPEUTICS INC | Mark Fishman, M.D. | 85.8% | Elected |
| ALGM — ALLEGRO MICROSYSTEMS INC | Yoshihiro (Zen) Suzuki | 85.8% | Elected |
| ATEX — ANTERIX INC | Leslie B. Daniels | 86.0% | Elected |
| DXCM — DEXCOM INC | Nicholas Augustinos | 88.3% | Elected |
| ALGM — ALLEGRO MICROSYSTEMS INC | Katsumi Kawashima | 88.8% | Elected |
| ACAD — ACADIA PHARMACEUTICALS INC | Laura A. Brege | 89.0% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Ted Love, M.D. | 92.9% | Elected |
| AXON — AXON ENTERPRISE INC | Julie Cullivan | 93.0% | Elected |
| JPM — JPMORGAN CHASE & CO | Stephen B. Burke | 93.0% | Elected |
| AXON — AXON ENTERPRISE INC | Michael Garnreiter | 93.6% | Elected |
| JPM — JPMORGAN CHASE & CO | James Dimon | 93.8% | Elected |
| AXON — AXON ENTERPRISE INC | Adriane Brown | 94.4% | Elected |
| ATEX — ANTERIX INC | Mahvash Yazdi | 94.4% | Elected |
| AXON — AXON ENTERPRISE INC | Graham Smith | 94.6% | Elected |
| DXCM — DEXCOM INC | Kevin R. Sayer | 94.9% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Pablo Legorreta | 95.0% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Frederick G. Vogt, Ph.D., J.D. | 95.1% | Elected |
| EXEL — EXELIXIS INC | Stelios Papadopoulos, Ph.D. | 95.1% | Elected |
| DXCM — DEXCOM INC | Bridgette P. Heller | 95.1% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Michael Weiser, M.D., Ph.D. | 95.6% | Elected |
| ATEX — ANTERIX INC | Jeffrey A. Altman | 96.1% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Ryan Maynard | 96.3% | Elected |
| FOLD — AMICUS THERAPEUTICS INC | Margaret G. McGlynn | 96.4% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Wayne P. Rothbaum | 96.5% | Elected |
| EXEL — EXELIXIS INC | Tomas J. Heyman | 96.5% | Elected |
| ACAD — ACADIA PHARMACEUTICALS INC | Elizabeth A. Garofalo, M.D. | 96.5% | Elected |
| JPM — JPMORGAN CHASE & CO | Todd A. Combs | 96.7% | Elected |
| IOVA — IOVANCE BIOTHERAPEUTICS INC | Wendy Yarno | 96.7% | Elected |
| NTRA — NATERA INC | Ruth Williams-Brinkley | 96.8% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Curtis W. Huff | 96.8% | Elected |
| DXCM — DEXCOM INC | Steven R. Altman | 97.0% | Elected |
| EXEL — EXELIXIS INC | Jack L. Wyszomierski | 97.2% | Elected |
| JPM — JPMORGAN CHASE & CO | Linda B. Bammann | 97.3% | Elected |
| GH — GUARDANT HEALTH INC | Vijaya Gadde | 97.4% | Elected |
| FOLD — AMICUS THERAPEUTICS INC | Glenn P. Sblendorio | 97.4% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Gregory Norden | 97.5% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | David Hodgson | 97.6% | Elected |
| FOLD — AMICUS THERAPEUTICS INC | Michael A. Kelly | 97.7% | Elected |
| DXCM — DEXCOM INC | Mark G. Foletta | 97.8% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Errol De Souza, Ph.D. | 98.0% | Elected |
| ACAD — ACADIA PHARMACEUTICALS INC | Catherine Owen Adams | 98.0% | Elected |
| EXEL — EXELIXIS INC | Maria C. Freire, Ph.D. | 98.0% | Elected |
| GH — GUARDANT HEALTH INC | Myrtle Potter | 98.1% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Tiffany (TJ) Thom Cepak | 98.1% | Elected |
| NVCR — NOVOCURE LTD | Kinyip Gabriel Leung | 98.2% | Elected |
| EXEL — EXELIXIS INC | Mary C. Beckerle, Ph.D. | 98.2% | Elected |
| AXON — AXON ENTERPRISE INC | Matthew McBrady | 98.3% | Elected |
| DXCM — DEXCOM INC | Richard A. Collins | 98.3% | Elected |
| ATEX — ANTERIX INC | Thomas R. Kuhn | 98.3% | Elected |
| DXCM — DEXCOM INC | Kyle Malady | 98.3% | Elected |
| AXON — AXON ENTERPRISE INC | Erika Ayers Badan | 98.4% | Elected |
| JPM — JPMORGAN CHASE & CO | Mark A. Weinberger | 98.5% | Elected |
| ATEX — ANTERIX INC | Scott A. Lang | 98.5% | Elected |
| ATEX — ANTERIX INC | William E. Heard | 98.6% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | William A. Hendricks, Jr. | 98.7% | Elected |
| JPM — JPMORGAN CHASE & CO | Virginia M. Rometty | 98.7% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Gary M. Halverson | 98.7% | Elected |
| EXEL — EXELIXIS INC | Julie Anne Smith | 98.7% | Elected |
| NVCR — NOVOCURE LTD | William Vernon | 98.7% | Elected |
| EXEL — EXELIXIS INC | George Poste, DVM, Ph.D., FRS | 98.7% | Elected |
| ATEX — ANTERIX INC | Mark A. Fleischhauer | 98.8% | Elected |
| GH — GUARDANT HEALTH INC | Roberto Mignone | 98.8% | Elected |
| AXON — AXON ENTERPRISE INC | Caitlin Kalinowski | 98.8% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Bonnie Bassler, Ph.D. | 98.9% | Elected |
| AXON — AXON ENTERPRISE INC | Jeri Williams | 98.9% | Elected |
| EXEL — EXELIXIS INC | Michael M. Morrissey, Ph.D. | 99.0% | Elected |
| NVCR — NOVOCURE LTD | William Doyle | 99.0% | Elected |
| EXEL — EXELIXIS INC | Robert L. Oliver, Jr. | 99.0% | Elected |
| AXON — AXON ENTERPRISE INC | Patrick Smith | 99.1% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | James C. Stewart | 99.1% | Elected |
| NVCR — NOVOCURE LTD | Asaf Danziger | 99.1% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Henry Fernandez | 99.1% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Leslie Beyer | 99.1% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Amy H. Nelson | 99.2% | Elected |
| JPM — JPMORGAN CHASE & CO | Phebe N. Novakovic | 99.2% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Julie J. Robertson | 99.2% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Catherine Engelbert | 99.2% | Elected |
| BEAM — BEAM THERAPEUTICS INC | Carole Ho, M.D. | 99.2% | Elected |
| EXEL — EXELIXIS INC | S. Gail Eckhardt, M.D. | 99.3% | Elected |
| EXEL — EXELIXIS INC | David E. Johnson | 99.3% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Janeen S. Judah | 99.3% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Robert W. Drummond | 99.3% | Elected |
| NVCR — NOVOCURE LTD | David Hung | 99.4% | Elected |
| NVCR — NOVOCURE LTD | Allyson Ocean | 99.4% | Elected |
| JPM — JPMORGAN CHASE & CO | Michele G. Buck | 99.4% | Elected |
| NVCR — NOVOCURE LTD | Martin Madden | 99.4% | Elected |
| NVCR — NOVOCURE LTD | Jeryl Hilleman | 99.4% | Elected |
| PTEN — PATTERSON UTI ENERGY INC | Cesar Jaime | 99.4% | Elected |
| NVCR — NOVOCURE LTD | Timothy Scannell | 99.4% | Elected |
| NVCR — NOVOCURE LTD | Kristin Stafford | 99.4% | Elected |
| RPRX — ROYALTY PHARMA PLC CLASS A | Vlad Coric, M.D. | 99.4% | Elected |
| BEAM — BEAM THERAPEUTICS INC | Kathleen Walsh | 99.5% | Elected |
| JPM — JPMORGAN CHASE & CO | Alex Gorsky | 99.5% | Elected |
| JPM — JPMORGAN CHASE & CO | Mellody Hobson | 99.5% | Elected |
| NVCR — NOVOCURE LTD | Ashley Cordova | 99.6% | Elected |
| JPM — JPMORGAN CHASE & CO | Alicia Boler Davis | 99.6% | Elected |
| RVMD — REVOLUTION MEDICINES INC | Frank K. Clyburn, Jr. | 99.7% | Elected |
| JPM — JPMORGAN CHASE & CO | Brad D. Smith | 99.7% | Elected |
| SLGN — SILGAN HOLDINGS INC | Adam J. Greenlee | 99.7% | Elected |
| DXCM — DEXCOM INC | Rimma Driscoll | 99.8% | Elected |
| DXCM — DEXCOM INC | Renée Galá | 99.8% | Elected |
| ALGM — ALLEGRO MICROSYSTEMS INC | Michael C. Doogue | 99.8% | Elected |
| SLGN — SILGAN HOLDINGS INC | Shannon Miller | 99.9% | Elected |
Showing 127 of 127 rows.
Sorted by highest support first — passed proposals lead, closest-to-passing failures follow. Board-proposed charter items are excluded.
| Company | Proposal | % For | Outcome | Filer |
|---|---|---|---|---|
| JPM — JPMORGAN CHASE & CO | Proposal on support for an independent board chairman | 36.6% | failed | Individual activist |
| JPM — JPMORGAN CHASE & CO | Proposal on report on social impacts of transition finance | 10.6% | failed | Ideological — progressive |
Showing 2 of 2 rows.
